No definition available.
Congenital malformations of great arteries
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MALFO_GREAT_ARTERIES
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
797 |
4. Check minimum number of eventsNone |
797 |
5. Include endpointsNone |
797 |
6. Filter based on genotype QC (FinnGen only) |
797 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Malformationes congenitae arteriarum magnarum
Similar endpoints
↥List of similar endpoints to
Congenital malformations of great arteries
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11820 | 5910 | 5895 |
| Only index persons | 7116 | 3524 | 3592 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.17 | 0.16 |
| Only index persons | 0.13 | 0.13 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 0.49 | 0.43 | 0.38 |
| Only index persons | 3.34 | 3.12 | 3.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 797 | 411 | 386 |
| Unadjusted period prevalence (%) | 0.15 | 0.14 | 0.17 |
| Median age at first event (years) | 13.14 | 12.71 | 13.59 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 710
- Matched controls
- 6999
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
323.0
308
*
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
298.4
266
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
14.0
197.7
411
627
Q23.11
ICD-10 Finland
Bicuspid aortic valve
1608.9
140.9
133
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
37.3
140.7
182
64
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
11.5
132.9
280
375
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
23.3
127.8
190
108
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
29.3
125.5
173
76
XF400
NOMESCO Finland
ECG with 12 standard connections
8.1
115.8
316
633
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
98.8
93
*
74719
ICD-8 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta
+∞
91.2
86
*
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
89.0
84
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
24.6
88.7
128
62
FM2CE
NOMESCO Finland
NA
12.6
87.4
166
165
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
86.9
82
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.9
85.2
412
1528
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
23.5
82.1
120
60
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
10.3
77.6
164
198
B01AA03
ATC
warfarin; systemic
8.4
77.3
187
285
7471A
ICD-9 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]
+∞
70.7
67
*
XF600
NOMESCO Finland
Bloodpressure measurement
7.7
70.0
180
297
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
68.5
65
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.3
66.3
159
234
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
72.7
64.3
73
11
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
58.0
62.9
74
14
31
HP
Congenital heart failure surgery
654.7
62.5
61
*
61
HP
Catheterization and pressure measurement of the left side of the heart
71.5
58.0
66
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.0
56.8
214
557
XF404
NOMESCO Finland
Ambulatory ECG
7.6
56.3
143
226
XF402
NOMESCO Finland
ECG with work load test
7.9
55.7
137
206
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
203.3
55.5
57
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
18.3
55.1
87
53
TPH07
NOMESCO Finland
Cathetrisation of artery
6.1
54.9
167
337
C03CA01
ATC
furosemide; systemic
5.3
52.7
182
426
ZXD10
NOMESCO Finland
Scheduled procedure
3.4
50.4
387
1838
ZXE20
NOMESCO Finland
More than three and less than five hours
4.8
50.3
192
499
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
+∞
49.3
47
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
43.0
48.4
60
15
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
48.2
46
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
48.0
342
1520
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
27.4
47.8
66
26
Q25.3
ICD-10 Finland
Stenosis of aorta
+∞
47.2
45
*
FDE32
NOMESCO Finland
Percutaneous transluminal closure of patent ductus arteriosus
+∞
47.2
45
*
Z2221
NOMESCO Finland
Medical doctor
3.3
44.8
304
1284
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
43.6
316
1394
62
HP
Catheterization and pressure measurement of the right side of the heart
230.8
43.2
44
*
C03DA01
ATC
spironolactone; oral
7.1
42.5
110
175
XFE00
NOMESCO Finland
Epicardial ultrasonography
18.4
41.6
65
38
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
4.9
41.0
149
360
Q25.6
ICD-10 Finland
Stenosis of pulmonary artery
+∞
40.8
39
*
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
40.8
39
*
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
+∞
39.8
38
*
Q25.48
ICD-10 Finland
Other congenital malformations of the aorta
+∞
39.8
38
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
39.0
270
1129
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
38.7
37
*
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
42.2
38.7
48
12
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.1
37.3
109
203
XF622
NOMESCO Finland
Measurement of minute volume of heart
71.3
36.1
41
6
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
370.3
36.1
36
*
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
+∞
34.5
33
*
Q21.30
ICD-10 Finland
Tetralogy of Fallot
+∞
32.4
31
*
Q25.78
ICD-10 Finland
Other congenital malformations of pulmonary artery
+∞
32.4
31
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
24.8
32.0
45
19
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
117.2
31.8
34
*
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
31.3
30
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
40.6
31.3
39
10
Z98.8
ICD-10 Finland
Other specified postsurgical states
21.0
31.0
46
23
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
113.6
30.7
33
*
C01AA05
ATC
digoxin; systemic
9.7
30.7
64
71
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
30.3
29
*
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
20.5
30.2
45
23
C07AB07
ATC
bisoprolol; oral
2.8
28.6
235
1056
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.3
27.0
61
78
PD5DG
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
277.2
26.8
27
*
WX402
NOMESCO Finland
General anaesthesia
2.8
26.2
201
858
WX872
NOMESCO Finland
Intensive care
7.4
26.1
64
93
74709
ICD-8 Finland
Other congenital anomalies of circulatory system, Patent ductus arteriosus
+∞
26.1
25
*
WX882
NOMESCO Finland
High dependency care
3.8
25.7
119
352
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
25.0
24
*
ZXD05
NOMESCO Finland
Urgent procedure
2.5
24.1
251
1266
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
+∞
24.0
23
*
Z3231
NOMESCO Finland
Registered nurse
2.3
23.7
301
1678
205
Kela drug reimbursment
Chronic hypertension
3.2
23.7
139
493
Q21.0
ICD-10 Finland
Ventricular septal defect
+∞
22.9
22
*
5513
FHL
Coarctation resection, plastic or bypass
+∞
22.9
22
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
+∞
21.9
21
*
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
21.9
21
*
K83
ICPC
Heart valve disease NOS
39.5
21.7
27
7
R4110
NOMESCO Finland
Physiotherapy
2.4
21.3
235
1208
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
+∞
20.8
20
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
20.8
20
*
FDJ00
NOMESCO Finland
End to end reconstruction of aorta for coarctation
+∞
20.8
20
*
FDJ42
NOMESCO Finland
Percutaneous transluminal angioplasty of thoracic aorta in coarctation
+∞
20.8
20
*
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
+∞
20.8
20
*
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
+∞
20.8
20
*
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
33.2
20.2
26
8
C07AB02
ATC
metoprolol; systemic
3.3
20.1
111
374
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.6
20.0
98
302
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
21.2
19.9
29
14
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
+∞
19.8
19
*
Q20.48
ICD-10 Finland
Single ventricle
+∞
19.8
19
*
XF620
NOMESCO Finland
Examination of circulation with color method
106.6
19.5
21
*
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
106.6
19.5
21
*
RS224
NOMESCO Finland
NA
10.9
18.9
36
34
WX704
NOMESCO Finland
Intubation
4.2
18.9
74
187
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
+∞
18.7
18
*
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
+∞
18.7
18
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.9
18.7
80
220
G04BE03
ATC
sildenafil; oral
12.6
18.6
33
27
I50.9
ICD-10 Finland
Heart failure, unspecified
4.7
18.5
64
143
C01BD01
ATC
amiodarone; systemic
10.9
17.9
34
32
XQ903
NOMESCO Finland
Production of other scan or drawing
53.2
17.9
21
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
3.4
17.8
93
301
ZXE00
NOMESCO Finland
One hour or less
2.0
17.7
327
2071
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
+∞
17.7
17
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
17.7
17
*
Q25.9
ICD-10 Finland
Congenital malformation of great arteries, unspecified
+∞
17.7
17
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
6.0
17.6
49
85
PD5BD
NOMESCO Finland
Extensive CT of aorta
15.3
16.6
27
18
WX892
NOMESCO Finland
Monitored bed care
3.3
16.4
87
284
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
20.4
16.4
24
12
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
40.5
16.3
20
5
TFP20
NOMESCO Finland
Cardiodefibrillation
5.2
15.9
50
101
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
+∞
15.6
15
*
Q25.8
ICD-10 Finland
Other congenital malformations of great arteries
+∞
15.6
15
*
FDE10
NOMESCO Finland
Ligature of patent ductus arteriosus
+∞
15.6
15
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
15.6
15
*
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
+∞
15.6
15
*
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
7.0
15.5
38
56
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
15.3
153
731
UGC02
NOMESCO Finland
Rigid bronchoscopy
9.9
14.7
29
30
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
14.6
14
*
Q21.32
ICD-10 Finland
Pulmonary atresia with Fallot ventricular septal defect
+∞
14.6
14
*
PC1BD
NOMESCO Finland
Extensive CT of thoracic aorta
150.9
14.4
15
*
7470A
ICD-9 Finland
Other congenital anomalies of circulatory system, Patent ductus arteriosus
150.9
14.4
15
*
PD5BG
NOMESCO Finland
MRI examination of thoracal and abdominal aortta with high intensity magnet
150.9
14.4
15
*
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
36.3
14.4
18
5
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
7.4
14.0
33
46
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
7.4
14.0
33
46
XF640
NOMESCO Finland
NA
8.5
14.0
30
36
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
+∞
13.5
13
*
I37.0
ICD-10 Finland
Pulmonary valve stenosis
+∞
13.5
13
*
7454B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]
+∞
13.5
13
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
+∞
13.5
13
*
FJE42
NOMESCO Finland
Percutaneous transluminal expansion of pulmonary valve
+∞
13.5
13
*
Q25.21
ICD-10 Finland
Interrupted aortic arch
+∞
13.5
13
*
Q25.70
ICD-10 Finland
Aneurysm, congenital of pulmonary artery
+∞
13.5
13
*
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
13.5
13
*
1EA01
NOMESCO Finland
NA
140.6
13.4
14
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.5
13.2
34
54
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
10.6
13.2
25
24
K84
ICPC
Heart disease other
8.9
13.0
27
31
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
12.8
155
805
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
70.2
12.5
14
*
Q20.00
ICD-10 Finland
Common arterial trunk
+∞
12.5
12
*
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
12.5
12
*
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
+∞
12.5
12
*
FXA13
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion
+∞
12.5
12
*
FBA96
NOMESCO Finland
Other suture or repair of pulmonary artery
+∞
12.5
12
*
Q25.4
ICD-10 Finland
Other congenital malformations of aorta
+∞
12.5
12
*
FLE96
NOMESCO Finland
Other repair of outlet obstruction of left ventricle
+∞
12.5
12
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.5
12.4
44
102
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.5
12.2
26
31
602
Kela drug reimbursment
Children's severe malnutrition
4.0
12.1
48
124
C09AA05
ATC
ramipril; oral
2.6
12.1
91
372
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
12.0
148
770
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.6
11.9
27
36
207
Kela drug reimbursment
Chronic arrhythmias
3.2
11.7
61
197
I44.2
ICD-10 Finland
Atrioventricular block, complete
9.7
11.7
23
24
7AX01
NOMESCO Finland
NA
19.0
11.5
17
9
RK260
NOMESCO Finland
NA
23.0
11.5
16
7
I28.8
ICD-10 Finland
Other specified diseases of pulmonary vessels
+∞
11.4
11
*
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
+∞
11.4
11
*
Q25.45
ICD-10 Finland
Congenital aortic aneurysm
+∞
11.4
11
*
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
120.2
11.4
12
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
11.3
192
1135
J01CA04
ATC
amoxicillin; systemic
2.1
11.1
625
5425
FCA50
NOMESCO Finland
Resection and reconstruction of ascending aorta using tube graft
43.4
10.9
13
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.6
10.8
48
137
R50.9
ICD-10 Finland
Fever, unspecified
2.0
10.6
161
907
B01AB05
ATC
enoxaparin; parenteral
2.1
10.6
130
673
C09AA02
ATC
enalapril; systemic
2.5
10.5
85
361
FJD20
NOMESCO Finland
Bypass of pulmonary valve with ventriculopulmonary prosthesis or homograft
+∞
10.4
10
*
21
HP
Aortic Valve Replacement (AVR)
+∞
10.4
10
*
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
+∞
10.4
10
*
FBE96
NOMESCO Finland
Other expansion or reconstruction of pulmonary artery
+∞
10.4
10
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
10.4
10
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
110.0
10.4
11
*
FCC45
NOMESCO Finland
Percutaneous insertion of stent into descending aorta
110.0
10.4
11
*
AP3
HP
Catheterization of the right and left side of the heart
32.6
10.3
13
*
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
18.8
10.2
15
8
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
18.8
10.2
15
8
ZX120
NOMESCO Finland
Intravenous
2.5
10.1
83
356
C07AA07
ATC
sotalol; systemic
6.3
10.1
26
42
FM1CD
NOMESCO Finland
Very extensive CT of heart
40.1
9.9
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
9.9
154
877
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
9.6
9.7
19
20
R62.0
ICD-10 Finland
Delayed milestone
3.0
9.7
57
201
81
HP
Angiography of the heart and coronary arteries
4.9
9.6
30
62
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
9.1
9.5
19
21
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
6.7
9.4
23
35
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
99.9
9.4
10
*
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
9.3
9
*
Q21.31
ICD-10 Finland
Tetralogy of Fallot and double outlet right ventricle
+∞
9.3
9
*
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
+∞
9.3
9
*
FMA20
NOMESCO Finland
Plastic repair of aortic valve for stenosis
+∞
9.3
9
*
Q24.0
ICD-10 Finland
Dextrocardia
+∞
9.3
9
*
FMD40
NOMESCO Finland
Replacement of aortic root using pulmonary autograft and reimplantation of coronary arteries (Ross)
+∞
9.3
9
*
7463A
ICD-9 Finland
Other congenital anomalies of heart, Congenital stenosis of aortic valve[STENOSIS VALVULAE AORTAE CONGENITA]
+∞
9.3
9
*
FHE30
NOMESCO Finland
Repair of tetralogy of Fallot with transannular patch
+∞
9.3
9
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
+∞
9.3
9
*
5609
FHL
Other measure in this category
+∞
9.3
9
*
Z2446
NOMESCO Finland
Social worker
2.0
9.3
123
655
WZC30
NOMESCO Finland
Teaching
2.3
9.2
87
401
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.3
9.0
23
37
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.9
9.0
24
41
F83
ICD-10 Finland
Mixed specific developmental disorders
3.1
9.0
48
159
FM1BD
NOMESCO Finland
Extensive CT of heart
36.7
9.0
11
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.4
8.9
73
313
I47.2
ICD-10 Finland
Ventricular tachycardia
8.6
8.7
18
21
ZX199
NOMESCO Finland
Other rote
6.6
8.6
21
32
AN1
HP
Coronary angiography
3.1
8.6
46
153
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
4.4
8.6
30
70
3A019
NOMESCO Finland
NA
11.6
8.5
15
13
PD5CD
NOMESCO Finland
Very extensive CT angiography of aorta
27.5
8.4
11
*
90492
NOMESCO Finland
NA
89.8
8.4
9
*
PD5CM
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
+∞
8.3
8
*
FCC50
NOMESCO Finland
Resection and reconstruction of descending aorta using tube graft
+∞
8.3
8
*
GAB00
NOMESCO Finland
Emergency thoracotomy
+∞
8.3
8
*
Q22.5
ICD-10 Finland
Ebstein anomaly
+∞
8.3
8
*
74699
ICD-8 Finland
Congenital anomalies of heart, Unspecified anomalies of heart
+∞
8.3
8
*
Q25.43
ICD-10 Finland
(Ruptured) aneurysm of sinus Valsalva
+∞
8.3
8
*
5207
FHL
VSD closure
+∞
8.3
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
8.3
44
146
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
8.1
122
682
Z3226
NOMESCO Finland
Physiotherapist
1.7
8.1
177
1122
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
8.0
47
166
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
33.3
8.0
10
*
WX870
NOMESCO Finland
Other postsurgical intensive care
11.7
8.0
14
12
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
8.0
189
1226
324
NOMESCO Finland
NA
22.0
8.0
11
5
3A077
NOMESCO Finland
NA
22.0
8.0
11
5
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.0
7.9
45
156
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.7
7.8
25
54
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
7.0
7.7
18
26
AB1
HP
AVR mechanical
44.8
7.7
9
*
FC1BC
NOMESCO Finland
Extensive angiography of thoracal aortta
44.8
7.7
9
*
ZXX09
NOMESCO Finland
Extent of procedure, more than 8 units
44.8
7.7
9
*
1CX08
NOMESCO Finland
NA
15.0
7.7
12
8
Z31.5
ICD-10 Finland
Genetic counselling
2.4
7.7
67
296
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
5.0
7.5
23
47
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
7.5
87
439
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.8
7.5
47
172
ZF61V
NOMESCO Finland
NA
79.8
7.4
8
*
5253
FHL
Cardiac lung machine
79.8
7.4
8
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
7.3
81
400
74659
ICD-8 Finland
Congenital anomalies of heart, Maleformatio valvulae mitralis
+∞
7.3
7
*
I37.2
ICD-10 Finland
Pulmonary valve stenosis with insufficiency
+∞
7.3
7
*
74673
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae aortae
+∞
7.3
7
*
FDE96
NOMESCO Finland
Other closure of patent ductus arteriosus
+∞
7.3
7
*
FBE00
NOMESCO Finland
Expansion of pulmonary artery
+∞
7.3
7
*
FDJ30
NOMESCO Finland
Reconstruction of aorta for coarctation using tube graft
+∞
7.3
7
*
5512
FHL
Cleavage or ligation of the ductus arteriosus
+∞
7.3
7
*
74619
ICD-8 Finland
Congenital anomalies of heart, Transposition of great vessels
+∞
7.3
7
*
Q20.8
ICD-10 Finland
Other congenital malformations of cardiac chambers and connections
+∞
7.3
7
*
Q25.5
ICD-10 Finland
Atresia of pulmonary artery
+∞
7.3
7
*
Q23.20
ICD-10 Finland
Congenital mitral stenosis
+∞
7.3
7
*
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
+∞
7.3
7
*
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
10.9
7.2
13
12
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
4.2
7.2
26
63
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
7.2
172
1113
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.8
7.2
44
161
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
15.7
7.2
11
7
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
2.9
7.1
42
150
I97.0
ICD-10 Finland
Postcardiotomy syndrome
29.9
7.1
9
*
R06.0
ICD-10 Finland
Dyspnoea
1.8
7.1
122
715
XG460
NOMESCO Finland
Short time oxymetry
6.0
7.0
18
30
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
8.8
7.0
14
16
C07AB03
ATC
atenolol; systemic
4.0
6.9
26
66
B34.9
ICD-10 Finland
Viral infection, unspecified
2.4
6.9
55
234
C08CA02
ATC
felodipine; oral
3.2
6.9
34
108
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
6.9
78
390
I27.0
ICD-10 Finland
Primary pulmonary hypertension
39.9
6.7
8
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
3.0
6.6
35
117
Q90.9
ICD-10 Finland
Down syndrome, unspecified
22.4
6.6
9
*
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
22.4
6.6
9
*
RS221
NOMESCO Finland
NA
3.5
6.6
29
85
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
6.5
119
707
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
12.2
6.5
11
9
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
69.5
6.4
7
*
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
69.5
6.4
7
*
AJ2
HP
Reconstruction of the ascending aorta
69.5
6.4
7
*
Q90
ICD-10 Finland
Down syndrome
69.5
6.4
7
*
I49.3
ICD-10 Finland
Ventricular premature depolarization
3.1
6.4
33
109
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
6.4
66
317
TFJ02
NOMESCO Finland
Muscle biopsy of heart
11.0
6.3
11
10
FDH10
NOMESCO Finland
Reconstruction of interrupted or hypoplastic aortic arch using patch
+∞
6.2
6
*
FLE00
NOMESCO Finland
Excision of subvalvular membrane of left ventricle
+∞
6.2
6
*
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
+∞
6.2
6
*
FAE96
NOMESCO Finland
Other connection to pulmonary artery from superior vena cava
+∞
6.2
6
*
AF1
HP
Surgery of congenital heart defect
+∞
6.2
6
*
Q21.20
ICD-10 Finland
Atrial septal defect of primum type
+∞
6.2
6
*
FBJ00
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery
+∞
6.2
6
*
Q26.3
ICD-10 Finland
Partial anomalous pulmonary venous connection
+∞
6.2
6
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
+∞
6.2
6
*
FDA96
NOMESCO Finland
Other operation for HLHS
+∞
6.2
6
*
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
6.2
6
*
74729
ICD-8 Finland
Other congenital anomalies of circulatory system, Maleformationes aortae aliae
+∞
6.2
6
*
FLE10
NOMESCO Finland
Myotomy or myectomy of left ventricle for outlet obstruction
+∞
6.2
6
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
6.2
6
*
7454A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]
+∞
6.2
6
*
FMC20
NOMESCO Finland
Suture of leaflet of aortic valve
+∞
6.2
6
*
Q23.9
ICD-10 Finland
Congenital malformation of aortic and mitral valves, unspecified
+∞
6.2
6
*
PD5DM
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
+∞
6.2
6
*
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
26.5
6.2
8
*
PD5AD
NOMESCO Finland
CT of aorta
7.0
6.2
14
20
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.1
101
582
I47.1
ICD-10 Finland
Supraventricular tachycardia
2.9
6.1
35
123
Z94.1
ICD-10 Finland
Heart transplant status
8.6
6.0
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
423
900
8.73
210.03
7.6
3.5
ng/l
1170.2
1061.8
0.23
397
738
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
233
249
12.58
202.58
5.0
5.1
ng/l
193.6
200.5
0.06
213
224
(3032080) INR in Blood by Coagulation assay
449
1548
5.25
119.08
17.2
5.8
inr
1.7
1.1
9.69
91
467
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
337
1344
3.54
64.14
3.2
3.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
157
362
5.06
63.86
12.2
8.4
%
83.9
93.5
4.93
157
356
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
242
790
3.89
62.19
6.6
3.2
ng/l
2544.2
362.1
3.13
200
487
(3044640) Blood type and Crossmatch panel - Blood
379
1673
3.34
60.41
3.2
3.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
35
12
29.92
51.65
6.0
12.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
80
134
6.41
45.50
24.2
12.0
u/ml
0.3
0.3
0.07
50
82
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
443
2425
2.79
43.88
4.6
4.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
114
289
4.35
40.42
2.3
2.2
ug/l
17.2
8.1
2.99
108
249
(3012095) Magnesium [Moles/volume] in Serum or Plasma
228
912
3.04
40.28
11.3
10.0
mmol/l
0.8
0.8
0.90
223
869
(3036489) Thrombin time
124
368
3.74
35.18
5.7
6.9
s
23.8
22.9
0.68
119
350
(3023368) Bacteria identified in Blood by Culture
263
1273
2.54
30.98
5.2
4.4
—
—
—
0
0
(3044889) 12 lead EKG panel
490
3135
2.39
30.62
4.7
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
119
392
3.33
28.51
61.0
15.8
inr
2.4
1.3
—
10
65
(3003396) Base excess in Arterial blood by calculation
131
459
3.16
28.34
26.2
10.2
mmol/l
0.5
0.5
0.01
114
360
(3038071) Oxygen [Partial pressure] in Mixed venous blood
35
9
39.89
28.00
6.0
13.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
86
240
3.82
26.44
33.2
13.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
736
6007
3.74
23.52
25.4
14.3
mmol/l
139.4
139.5
0.59
726
5840
(3023103) Potassium [Moles/volume] in Serum or Plasma
734
6009
3.60
22.72
25.2
14.4
mmol/l
4.0
4.0
1.36
723
5817
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
144
4.34
22.58
1.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
165
740
2.50
22.00
2.2
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
495
3462
2.07
21.18
13.4
6.8
mmol/l
6.2
6.3
0.97
469
3212
(3000494) Fungus identified in Specimen by Culture
143
612
2.58
20.96
1.6
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
179
850
2.38
20.96
3.0
2.9
g/l
2.5
2.5
0.21
173
804
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
170
796
2.40
20.51
3.0
3.0
%
21.1
22.7
0.94
156
739
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
400
2612
2.01
20.48
9.6
7.9
umol/l
23.4
19.1
1.31
378
2455
(3018738) Hemoglobin F/Hemoglobin.total in Blood
32
47
6.92
20.45
4.4
4.7
%
6.1
4.4
0.24
13
21
(3003458) Phosphate [Moles/volume] in Serum or Plasma
220
1175
2.16
19.24
12.8
10.8
mmol/l
1.3
1.3
0.32
214
1119
(3024928) Oxygen saturation in Venous blood
57
150
3.94
18.96
11.3
17.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
245
1387
2.06
18.23
4.0
3.0
ng/l
71.6
33.0
1.37
159
785
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
171
848
2.25
17.84
2.2
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
304
1881
1.95
17.42
1.5
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
197
1048
2.12
17.16
21.2
11.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
138
656
2.29
15.79
2.1
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
138
661
2.27
15.49
2.2
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
208
1172
2.01
15.30
4.6
3.4
mg/l
1.9
1.5
0.50
146
881
(3011648) Oxygen content in Venous blood
39
91
4.37
15.20
11.8
25.8
%
11.6
11.7
0.05
39
91
(40761511) CBC panel - Blood by Automated count
744
6455
3.06
14.47
17.4
10.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
225
1340
1.91
13.89
3.2
2.5
u/l
437.0
311.9
0.84
218
1277
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
397
2842
1.74
13.08
21.3
11.7
mmol/l
1.2
1.2
10.32
384
2682
(3002032) Base excess in Venous blood by calculation
200
1171
1.90
12.88
9.5
10.4
mmol/l
1.4
1.2
0.39
164
922
(3022313) Gas panel - Capillary blood
173
969
1.96
12.69
12.7
10.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
290
1918
1.76
12.48
4.6
4.7
u/l
42.1
33.3
1.04
283
1832
(3013512) EKG study
180
1039
1.91
12.01
5.4
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
729
6367
2.50
11.97
19.1
12.3
mg/l
27.8
23.0
3.10
593
4611
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
410
3030
1.68
11.47
16.7
11.4
mmol/l
1.2
1.2
5.66
372
2740
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
189
1130
1.84
11.23
14.2
10.4
kpa
5.2
5.0
3.58
184
1079
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
187
1116
1.84
11.17
14.2
10.4
mmol/l
2.0
0.7
12.16
160
774
(3009343) pH of Capillary blood
188
1127
1.84
11.05
14.2
10.4
ph
7.4
7.4
0.35
11
43
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
236
1547
1.71
10.08
3.1
3.0
mg/l
3.1
2.8
1.45
212
1362
(3024561) Albumin [Mass/volume] in Serum or Plasma
306
2152
1.64
9.97
9.1
7.4
g/l
36.1
36.9
1.19
291
2047
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
19
35
5.44
9.72
1.6
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
504
4025
1.63
9.62
7.7
6.7
u/l
100.1
106.3
0.98
482
3780
(3007853) Bacteria identified in Skin by Aerobe culture
138
807
1.82
8.63
2.0
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
465
3694
1.57
8.62
7.8
8.9
e9/l
0.6
0.6
0.97
408
3085
(3006315) Basophils [#/volume] in Blood
464
3698
1.56
8.37
7.8
8.9
e9/l
0.0
0.0
0.11
408
3089
(3013115) Eosinophils [#/volume] in Blood
475
3807
1.56
8.34
8.8
9.6
e9/l
0.2
0.2
0.93
424
3253
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
304
2214
1.56
8.16
3.9
4.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
164
1027
1.72
8.07
8.8
10.3
mmol/l
23.9
23.6
0.87
159
986
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
43
162
2.70
8.05
2.2
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
195
1283
1.65
7.96
2.9
3.2
mosm/kgh2o
564.9
575.6
0.22
179
1100
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
526
4337
1.56
7.95
14.2
9.7
ml/min/173m2
92.9
93.1
0.05
433
3257
(3002385) Erythrocyte distribution width [Ratio]
680
5980
1.81
7.91
26.1
16.4
%
13.5
13.4
3.10
673
5897
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
237
2.37
7.81
2.2
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
471
3803
1.53
7.72
8.0
8.8
e9/l
1.9
2.3
8.55
421
3272
(42870588) Differential panel, method unspecified - Blood
361
2761
1.52
7.60
7.8
9.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
168
2.60
7.51
1.7
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
54
238
2.32
7.30
2.2
2.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
434
3469
1.50
7.28
7.9
9.2
%
0.6
0.6
1.25
420
3336
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
184
2.49
7.17
1.5
2.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
442
3560
1.49
7.05
8.2
9.4
%
8.8
8.4
2.12
427
3426
(3006504) Eosinophils/100 leukocytes in Blood
439
3542
1.48
6.86
7.9
9.2
%
2.9
3.2
1.90
424
3398
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
41
164
2.53
6.84
2.2
3.9
%
12.3
9.0
0.90
32
150
(3019060) Gas panel - Arterial blood
50
221
2.30
6.73
10.6
6.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
492
4079
1.48
6.59
10.5
11.5
e9/l
3.9
3.6
1.82
440
3426
(3027945) Reticulocytes/100 erythrocytes in Blood
133
837
1.67
6.34
5.8
6.0
%
1.6
1.5
0.83
125
788
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
26
4.98
6.08
1.5
1.4
e6/l
24210.0
22122.5
—
8
16
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
30
4.65
6.07
1.9
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
271
2024
1.48
6.05
3.7
4.2
e6/l
39.7
70.4
0.37
222
1521
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
226
2.20
5.99
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
226
2.20
5.99
1.7
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
189
1316
1.54
5.89
2.9
3.3
e6/l
4.6
5.4
0.45
172
1139
(3045788) Cell count panel - Pleural fluid
12
23
5.19
5.87
1.2
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
38
160
2.40
5.73
1.6
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
448
3702
1.43
5.72
7.9
9.0
%
29.1
34.0
13.32
432
3563
(3011412) CD3 cells [#/volume] in Blood
41
179
2.32
5.70
2.2
3.7
e9/l
1.0
1.6
4.04
35
113
(44790047)
41
179
2.32
5.70
2.4
2.3
—
—
—
0
0
(44790049)
41
179
2.32
5.70
2.4
2.3
—
—
—
0
0
(44790048)
41
179
2.32
5.70
2.4
2.3
—
—
—
0
0
(44806118)
41
179
2.32
5.70
2.4
2.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
42
186
2.29
5.66
1.6
2.1
g/l
1.3
1.3
0.05
27
162
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
13
28
4.62
5.60
2.0
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
368
2945
1.42
5.56
3.8
3.2
ug/l
79.7
80.6
0.05
352
2777
(3021960) Folate [Moles/volume] in Serum or Plasma
139
916
1.59
5.48
1.5
1.4
nmol/l
23.5
21.2
0.85
123
789
(3030467) Casts [#/volume] in Urine by Automated count
253
1894
1.46
5.48
3.5
4.1
e6/l
0.2
0.3
0.78
202
1394
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
64
338
1.93
5.47
3.2
2.6
ml/min/173m2
70.1
74.6
0.31
27
125
(3018010) Neutrophils/100 leukocytes in Blood
440
3643
1.42
5.44
7.9
8.9
%
55.3
50.7
10.88
426
3514
(3021589) Normoblasts [#/volume] in Blood
422
3474
1.41
5.36
11.0
11.2
e9/l
0.0
0.0
0.28
344
2690
(3012441) Differential panel - Pleural fluid
12
26
4.59
5.14
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
186
1327
1.49
5.10
5.7
5.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
127
834
1.59
5.07
5.5
6.0
umol/l
9.2
7.2
0.80
116
696
(3021901) Oxygen saturation in Capillary blood
31
126
2.47
5.06
4.8
7.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
773
7269
2.60
5.00
29.2
18.1
e9/l
6.9
6.8
0.33
753
6952
(3007461) Platelets [#/volume] in Blood
772
7259
2.53
4.92
29.2
18.1
e9/l
246.3
263.9
11.03
757
6962
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
59
315
1.91
4.90
3.2
5.0
mmol/l
1.2
1.2
0.26
54
277
(3024731) MCV [Entitic volume]
772
7264
2.51
4.82
29.2
18.0
fl
88.4
87.9
1.92
766
7180
(3026361) Erythrocytes [#/volume] in Blood
772
7266
2.50
4.78
29.2
18.0
e12/l
4.5
4.6
3.78
753
6947
(3018095) Leukocytes [#/volume] in Urine
298
2346
1.40
4.74
4.5
5.0
e6/l
113.3
58.9
0.26
226
1592
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
205
1513
1.45
4.68
3.5
2.9
u/l
59.9
56.4
0.56
191
1406
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
78
2.82
4.68
2.2
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
772
7271
2.47
4.68
31.1
18.2
g/l
132.4
134.9
4.01
765
7186
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
18
57
3.15
4.64
1.8
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
246
1885
1.41
4.55
3.5
4.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
771
7265
2.40
4.53
29.2
18.0
pg
29.6
29.5
0.95
766
7180
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
11
8.11
4.51
2.8
4.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
16
48
3.32
4.48
4.3
2.8
mmol/l
4.1
4.0
0.07
16
48
(3018418) pH of Serum or Plasma
195
1437
1.44
4.47
5.0
4.2
ph
7.4
7.4
0.24
46
224
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
21
4.72
4.43
1.9
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
272
2129
1.39
4.41
7.2
9.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
63
356
1.80
4.41
2.2
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
110
725
1.57
4.32
1.8
1.6
pmol/l
459.5
18367805.4
0.79
96
637
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
315
1.84
4.29
1.7
1.8
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
14
40
3.48
4.22
1.1
1.1
%
85.8
91.4
—
9
19
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
28
120
2.34
4.12
1.9
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
7
9.89
3.97
17.7
16.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
15
47
3.18
3.94
4.5
2.8
mmol/l
105.3
106.1
0.26
15
47
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
85
540
1.61
3.90
7.5
7.6
ng/l
66.1
58.2
0.65
77
518
(40767503) Oxygen content in Capillary blood by calculation
25
105
2.38
3.86
4.6
2.9
%
18.1
17.4
0.31
14
65
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
38
3.40
3.80
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
188
1414
1.40
3.79
4.4
3.5
estimate
0.0
0.0
0.88
67
489
(3031040) Bacteria [#/volume] in Urine by Automated count
439
3764
1.32
3.71
4.4
4.1
e6/l
8.6
82.7
—
5
42
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
95
2.42
3.69
2.2
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
13
39
3.31
3.66
1.4
1.1
%
69.4
90.2
—
8
18
(3024891) Influenza virus A+B Ag [Presence] in Specimen
59
347
1.72
3.64
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
34
167
2.04
3.63
12.1
5.6
—
—
—
0
0
(4034850)
31
147
2.11
3.62
11.5
9.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
16
5.57
3.61
2.8
3.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
15
50
2.98
3.58
5.3
2.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
668
6125
1.44
3.54
26.8
16.4
g/l
334.3
334.6
0.40
663
6076
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
46
3.02
3.43
4.8
2.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
14
46
3.02
3.43
2.4
5.6
—
—
—
0
0
(3002256) Pathology report gross observation
83
546
1.55
3.31
1.3
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
25
113
2.21
3.30
11.6
10.2
mmol/l
1.1
1.1
0.21
25
95
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
37
3.22
3.25
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
55
330
1.68
3.18
4.2
3.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
33
169
1.96
3.17
2.0
3.6
e9/l
0.2
0.2
0.76
26
121
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
38
3.13
3.12
1.5
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
117
2.13
3.05
2.3
4.2
%
57.5
52.7
1.08
25
117
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
681
6305
1.42
3.05
11.9
9.9
u/l
28.3
27.2
0.51
663
6110
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
62
391
1.60
2.97
3.3
2.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
24
112
2.14
2.96
3.9
5.5
kpa
8.2
9.1
0.92
24
112
(3026493) Urate [Moles/volume] in Serum or Plasma
149
1126
1.37
2.88
4.2
3.9
umol/l
3763.4
3479.3
0.03
131
1015
(4268621)
17
69
2.45
2.86
2.1
2.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
87
599
1.48
2.82
5.4
4.3
e9/l
67.2
64.3
0.30
61
398
(3002179) Metamyelocytes/100 leukocytes in Blood
61
389
1.58
2.80
4.4
5.2
%
0.6
0.4
0.33
13
93
(3006184) Hemoglobin [Mass/volume] in Capillary blood
27
135
2.00
2.80
4.2
2.5
g/l
141.5
134.9
0.41
18
105
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
178
1.86
2.76
1.4
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
14
53
2.62
2.71
1.6
2.5
%
33.7
43.6
—
8
15
(3051387) C reactive protein [Mass/volume] in Capillary blood
22
103
2.13
2.71
3.0
3.5
mg/l
21.1
28.9
0.59
16
62
(3019309) Folate [Moles/volume] in Red Blood Cells
82
563
1.48
2.70
1.7
1.6
nmol/l
1122.8
1188.9
0.26
66
431
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
32
172
1.86
2.70
2.1
3.6
e6/l
379.0
575.4
2.14
26
122
(3051611) Lipemic interference index of Serum or Plasma
20
90
2.21
2.70
4.6
5.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
45
697
0.61
2.65
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
104
2.11
2.65
1.3
1.2
u/ml
1.6
2.7
—
8
45
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
153
1.89
2.60
1.9
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
105
2.09
2.59
1.2
1.2
u/ml
4.4
3.2
0.22
14
54
(3012501) Base excess in Blood by calculation
23
112
2.05
2.57
3.7
5.5
mmol/l
1.6
2.3
0.92
13
63
(3013290) Carbon dioxide [Partial pressure] in Blood
23
112
2.05
2.57
3.7
5.5
kpa
5.0
4.9
0.37
23
112
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
417
3656
1.25
2.55
4.1
4.1
u/l
47.9
39.4
1.47
391
3496
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
49
2.63
2.54
1.6
2.3
pg
31.7
33.3
0.76
13
49
(3025159) Blasts/100 leukocytes in Blood
60
391
1.55
2.53
5.0
5.8
%
0.0
0.1
0.82
14
106
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
120
1.99
2.51
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
690
6448
1.39
2.50
27.7
15.1
%
39.1
39.7
1.64
596
5484
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
120
1519
0.74
2.48
1.6
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
142
1.90
2.45
1.9
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
158
0.31
2.43
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
137
1.89
2.36
2.6
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
74
998
0.70
2.25
1.2
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
78
2.17
2.22
4.4
5.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
63
428
1.48
2.22
5.1
5.6
%
0.5
0.6
0.13
16
133
(3026008) Bacteria identified in Urine by Culture
182
1469
1.28
2.20
3.0
2.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
30
170
1.76
2.19
2.4
3.7
—
39.6
—
0
5
(1616796) Gas panel - Central venous blood
24
127
1.88
2.17
4.8
4.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
59
398
1.49
2.16
5.1
5.8
%
0.0
0.1
2.37
15
121
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
53
352
1.51
2.09
3.4
3.6
pmol/l
4.6
4.9
1.69
48
321
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
188
0.41
2.07
2.0
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
116
1.89
2.02
2.3
3.7
e9/l
4.2
3.8
0.36
22
116
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
153
1222
1.28
2.01
3.2
3.6
e6/l
0.7
0.8
0.29
90
700
(3052851) Hemolysis interference index of Serum or Plasma
34
206
1.65
1.98
4.3
3.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
331
2886
1.22
1.97
3.9
3.4
estimate
0.0
0.0
0.80
72
486
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
69
2.16
1.97
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
69
2.16
1.97
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
63
440
1.44
1.96
3.1
3.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
76
2.09
1.95
3.4
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
95
713
1.35
1.94
4.4
3.5
g/l
8.4
9.2
1.60
90
680
(3021601) Nitrite [Presence] in Urine by Test strip
328
2861
1.21
1.94
5.2
4.9
estimate
0.0
0.0
0.50
72
508
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
7
21
3.29
1.93
1.0
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
97
1.95
1.92
6.4
5.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
62
434
1.44
1.91
9.5
6.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
6
16
3.70
1.90
3.8
3.5
mmol/l
4.2
4.6
—
6
16
(3016879) Cocaine [Presence] in Urine
33
505
0.63
1.90
2.5
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
27
2.93
1.90
1.4
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
112
1.86
1.88
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
326
2849
1.21
1.87
3.9
3.4
estimate
0.0
0.0
0.00
67
479
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
105
1.89
1.87
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
371
0.57
1.86
2.9
2.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
508
4634
1.21
1.85
3.9
3.7
pmol/l
14.9
14.5
2.86
477
4271
(3010421) pH of Blood
23
128
1.79
1.81
4.1
5.1
ph
7.4
7.4
0.16
23
112
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
6
17
3.48
1.80
1.5
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
40
259
1.54
1.80
3.4
3.7
e6/l
0.1
0.1
0.21
40
251
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
12
238
0.49
1.73
1.0
1.1
u/ml
4.2
0.4
—
6
113
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
20
109
1.82
1.69
3.5
4.6
umol/l
26.7
25.3
0.40
20
109
(4306422)
17
88
1.92
1.67
1.1
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
148
1207
1.25
1.64
3.4
3.8
e6/l
2.8
1.9
0.41
86
693
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
333
0.58
1.64
1.9
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
206
2329
0.82
1.63
1.5
1.7
u/ml
1.1
2.9
3.01
43
432
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
111
1.79
1.61
1.6
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
366
0.61
1.59
1.5
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
518
0.67
1.59
1.5
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
14
3.52
1.59
1.0
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
69
2.01
1.58
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
69
2.01
1.58
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
26
2.66
1.55
1.0
1.6
g/l
0.9
1.1
—
7
26
(3020393) Adenovirus Ag [Presence] in Stool
21
120
1.74
1.54
1.6
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
422
0.64
1.54
2.4
1.9
—
—
—
0
0
(3024932) HLA-DR beta [Type]
13
63
2.04
1.53
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
38
535
0.68
1.51
2.3
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
15
3.29
1.50
1.6
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
519
4789
1.19
1.49
4.3
3.8
mmol/l
4.4
4.6
5.33
500
4528
(3037467) Urinalysis macro (dipstick) panel - Urine
440
4005
1.18
1.49
4.4
4.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
533
0.69
1.48
2.3
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
13
64
2.01
1.48
1.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
21
2.82
1.47
1.5
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
193
1644
1.20
1.41
3.4
3.3
mmol/l
2.4
2.4
1.21
181
1488
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
170
1.58
1.41
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
235
2038
1.19
1.41
4.0
3.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
39
538
0.70
1.40
2.4
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32
210
1.52
1.40
11.1
10.8
iu/ml
254.4
467.3
—
5
35
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
495
4562
1.17
1.40
3.9
3.4
mmol/l
1.3
1.2
0.30
475
4287
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
445
0.67
1.38
1.0
1.2
u/ml
4.4
5.9
0.43
20
337
(3027008) Opiates [Presence] in Urine
39
535
0.70
1.36
2.3
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
38
0.00
1.34
0.0
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
23
2.57
1.34
1.5
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
42
2.12
1.31
1.2
1.9
umol/l
12.8
10.3
—
9
42
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
142
1.61
1.31
1.7
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
112
1.68
1.28
2.1
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
34
2.32
1.28
1.8
3.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
43
2.07
1.27
1.3
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
437
0.68
1.27
1.0
1.2
u/ml
1.5
1.1
0.24
18
313
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.86
1.23
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
69
1.86
1.23
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
329
0.65
1.21
2.4
1.8
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
25
162
1.53
1.18
2.2
3.8
e6/l
320.6
388.8
0.54
18
103
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
70
1.84
1.18
4.9
5.3
—
—
—
0
0
(4146454)
0
32
0.00
1.16
0.0
3.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
32
0.00
1.16
0.0
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.6
—
2.1
—
0
19
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
428
0.70
1.15
1.1
1.2
u/ml
3.3
4.5
0.27
12
145
(3000034) Microalbumin [Mass/volume] in Urine
0
35
0.00
1.15
0.0
2.8
—
22.1
—
0
28
(3037756) Immunofixation for Serum or Plasma
11
57
1.91
1.12
1.1
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
30
2.30
1.11
1.0
2.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
43
315
1.36
1.10
1.7
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
87
1.71
1.09
2.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
51
1.94
1.06
1.0
1.5
nmol/l
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
46
343
1.34
1.06
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
413
1.30
1.05
2.2
2.4
u/l
5646.8
4259.9
0.12
20
143
(3037121) Protein [Mass/volume] in Urine
46
345
1.33
1.03
4.3
7.9
g/l
0.4
0.4
0.04
35
246
(4062490)
20
128
1.55
1.02
1.6
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
194
1.43
1.00
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
121
1.56
0.99
4.1
2.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
245
1.38
0.98
2.4
2.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
183
0.58
0.97
1.3
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
21
138
1.51
0.96
3.9
2.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
99
1.60
0.94
4.8
3.5
—
—
—
0
0
(4094501)
16
99
1.60
0.94
1.4
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
27
2.19
0.92
1.8
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
180
0.59
0.92
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
179
0.60
0.90
1.3
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
34
249
1.36
0.90
4.3
3.8
umol/l
30.8
36.8
1.66
34
226
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
226
0.65
0.90
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
176
1546
1.15
0.89
3.8
3.3
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
5
103
0.47
0.89
1.0
1.2
u/ml
0.0
16.4
—
5
94
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
310
1.32
0.89
1.8
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
174
1.42
0.88
1.6
1.8
g/l
0.7
0.8
0.19
17
147
(1002224) Polysomnography panel
14
213
0.64
0.88
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
218
2343
0.88
0.86
2.0
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
157
1725
0.87
0.86
2.5
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
187
1655
1.14
0.85
2.1
1.7
pmol/l
91.3
96.7
0.89
108
840
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
257
0.68
0.84
1.2
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
12
71
1.67
0.84
1.2
1.5
mmol/l
5.5
7.3
—
7
49
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
511
4807
1.12
0.84
4.6
4.0
mmol/l
2.6
2.8
2.88
490
4495
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
56
1.76
0.83
3.0
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
127
1.48
0.83
1.7
1.4
g/l
5.5
6.4
0.49
14
106
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
504
4743
1.12
0.81
4.1
3.7
mmol/l
1.4
1.4
1.47
485
4453
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
14
208
0.65
0.80
2.9
2.2
nmol/l
0.7
0.6
0.25
14
181
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
443
0.77
0.80
1.4
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
104
1171
0.85
0.79
2.4
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
30
221
1.35
0.79
1.4
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
120
0.57
0.78
1.3
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.9
—
0.8
—
0
20
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
33
1.79
0.77
5.2
5.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
396
0.76
0.76
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
75
623
1.20
0.76
2.6
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
208
2225
0.89
0.75
1.7
1.7
g/l
1.9
1.8
0.66
134
1167
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
72
833
0.83
0.75
4.0
3.7
%
23.8
21.5
0.49
35
343
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
23
2.14
0.75
1.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
23
2.14
0.75
1.4
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
23
2.14
0.75
2.0
1.2
u/l
364.4
384.4
—
5
23
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
98
835
1.17
0.75
1.2
1.2
iu/ml
27.1
28.7
0.06
20
237
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
496
4674
1.11
0.75
4.0
3.4
mmol/l
5.6
5.7
0.66
460
4298
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
372
0.76
0.74
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
131
0.60
0.74
1.3
4.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
181
1.37
0.74
1.3
1.3
ug/g
276.3
350.1
0.87
15
101
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
105
0.56
0.73
1.0
1.3
u/ml
1.7
8.1
—
6
95
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
38
1.82
0.73
1.3
1.6
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
20
271
0.72
0.73
1.0
1.0
mmol/l
-1.9
-2.5
—
6
68
(3006598) pH of Arterial cord blood
20
271
0.72
0.73
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
20
271
0.72
0.73
1.0
1.0
kpa
7.2
7.3
0.06
20
235
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
20
271
0.72
0.73
1.0
1.0
mmol/l
20.2
19.5
0.67
20
266
(3023410) Appearance of Cerebral spinal fluid
11
168
0.64
0.72
1.5
5.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
303
1.28
0.72
2.8
2.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
25
1.97
0.72
1.0
1.4
nmol/l
130.0
149.4
—
5
25
(3042631) Mycobacterium sp identified in Specimen
7
39
1.77
0.71
2.4
5.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
270
0.72
0.71
2.8
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
99
1.50
0.71
1.7
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
99
1.50
0.71
1.9
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
26
1.89
0.69
1.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
148
1311
1.13
0.68
4.3
3.2
kg/l
1.0
1.0
0.21
18
228
(3037522) Nuclear Ab [Titer] in Serum
100
862
1.16
0.68
1.5
1.5
titre
280.0
531.1
1.81
18
151
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
210
1.32
0.67
1.3
2.6
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
20
267
0.73
0.67
1.0
1.0
kpa
3.1
3.3
0.53
20
232
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
473
0.80
0.66
1.2
1.3
u/ml
1.4
2.7
0.44
20
313
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
232
0.71
0.66
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
232
0.71
0.66
1.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
26
194
1.33
0.65
1.2
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
40
317
1.25
0.65
2.1
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
28
1.76
0.65
1.4
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
61
1.62
0.64
1.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
13
85
1.51
0.64
3.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
231
0.72
0.64
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
231
0.72
0.64
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
231
0.72
0.64
1.4
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
44
1.57
0.64
1.9
3.0
nmol/l
33.5
3.0
—
7
44
(3017143) Hepatitis C virus Ab [Presence] in Serum
105
914
1.15
0.63
1.7
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
29
1.70
0.62
1.4
2.4
—
1.3
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
101
0.58
0.62
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
70
1.55
0.61
1.1
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
138
0.64
0.60
4.3
4.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
174
1570
1.11
0.60
2.2
2.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
227
0.73
0.59
3.2
2.4
u/ml
30.6
35.5
0.15
17
216
(3032868) Hemoglobin electrophoresis panel in Blood
0
22
0.00
0.59
0.0
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
63
1.57
0.58
1.2
4.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
248
0.75
0.57
1.4
1.4
mg/l
2.7
3.4
—
10
172
(3041096) Erythrocytes [Presence] in Urine by Automated
161
1452
1.11
0.56
3.5
3.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
139
1.35
0.55
1.8
2.9
—
672.4
—
0
20
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
97
1.42
0.55
2.0
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
22
166
1.31
0.53
1.2
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
38
1.55
0.53
1.0
1.5
umol/l
20.1
17.1
—
6
38
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
568
5433
1.09
0.53
4.7
4.2
mu/l
2.0
1.9
0.73
535
5063
(40765089) Chromosome analysis panel - Blood by G-banded
6
96
0.61
0.52
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
39
1.51
0.52
1.2
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
39
1.51
0.52
1.2
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
39
1.51
0.52
1.2
1.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
6
98
0.60
0.52
1.0
1.4
—
290.0
—
0
5
(3044941) Cell count panel - Synovial fluid
9
63
1.41
0.51
2.3
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
209
0.75
0.50
1.3
1.5
u/ml
6.5
10.2
—
9
147
(3020874) Milk IgE Ab [Units/volume] in Serum
17
220
0.75
0.50
1.2
1.5
u/ml
0.5
4.3
2.82
12
159
(4010399)
43
356
1.20
0.50
1.4
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
265
2463
1.08
0.49
3.8
3.2
nmol/l
75.3
72.2
1.04
244
2297
(3000093) Morphology [Interpretation] in Blood Narrative
12
83
1.43
0.48
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
52
441
1.17
0.47
2.5
2.0
u/l
6.3
6.7
0.13
41
280
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
117
0.67
0.46
1.1
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
249
0.78
0.45
1.1
1.1
u/ml
3.4
9.9
3.01
13
148
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
141
1280
1.10
0.45
1.6
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
138
0.71
0.44
1.2
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
110
1179
0.90
0.43
2.4
3.2
ug/g
144.4
104.5
0.24
93
960
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14
102
1.35
0.43
1.1
1.8
umol/l
5.0
3.6
0.87
14
93
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
511
0.86
0.43
1.7
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
31
1.59
0.42
1.0
1.1
—
—
—
0
0
(44813793)
6
94
0.62
0.42
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
267
0.80
0.42
1.1
1.1
u/ml
13.4
9.0
0.28
14
153
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
32
1.54
0.41
1.0
1.2
u/l
219.0
609.0
—
5
26
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
78
689
1.12
0.41
2.4
2.6
mmol/l
2.4
2.4
1.17
64
587
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
75
818
0.89
0.41
1.3
1.2
u/ml
15.6
7.6
0.36
29
293
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
86
1.38
0.41
2.4
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
58
1.36
0.41
1.4
1.2
promille
0.7
1.4
—
8
47
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
3.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
135
0.72
0.40
1.1
1.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
268.1
—
0
9
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
523.7
—
0
9
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
40.8
—
0
8
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
145
1327
1.09
0.39
1.9
1.8
mmol/l
1.4
1.3
0.44
132
1165
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
748
1.11
0.39
2.8
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
148
1.27
0.39
3.5
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
452
4314
1.07
0.39
5.3
4.7
mmol/mol
37.2
38.5
2.43
429
4068
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
122
1.29
0.38
1.3
1.3
—
1.2
—
0
7
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
212
1.21
0.37
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
48
414
1.15
0.37
3.3
2.3
e9/l
4.1
4.2
0.11
41
368
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
76
0.64
0.36
1.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
41
1.44
0.35
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
78
0.63
0.35
1.6
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
42
1.41
0.35
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
43
1.37
0.34
1.5
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
174
0.79
0.33
1.1
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
215
1.19
0.33
1.2
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
46
1.28
0.32
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
73
784
0.91
0.32
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
51
1.35
0.31
1.0
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
51
1.35
0.31
1.0
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
51
1.35
0.31
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
51
1.35
0.31
1.0
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
225
0.83
0.31
1.3
4.2
e6/l
9.8
7.2
0.14
13
162
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
19
225
0.83
0.31
1.4
4.3
e6/l
7106.0
996.2
0.46
14
167
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
53
1.30
0.30
1.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
497
1.11
0.30
1.4
1.3
iu/ml
126.5
151.6
0.17
18
169
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
38
329
1.14
0.29
3.7
4.4
ug/l
13.6
20.9
0.17
27
258
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
105
0.75
0.29
1.3
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
219
1.17
0.28
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
61
1.29
0.28
1.1
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
122
1271
0.93
0.28
2.4
2.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
60
538
1.10
0.27
2.6
2.2
nmol/l
11.0
12.3
0.52
52
450
(3013707) Erythrocyte sedimentation rate by Westergren method
448
4305
1.05
0.27
5.0
4.4
mm/h
10.3
8.9
1.34
426
4015
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
158
0.80
0.27
1.2
1.3
u/ml
0.6
22.5
—
8
129
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
346
0.87
0.26
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
239
1.16
0.26
1.8
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
50
447
1.11
0.24
2.6
2.0
iu/l
15.6
13.6
0.26
42
308
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
80
0.73
0.24
1.2
4.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
80
0.73
0.24
1.2
4.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
552
1.09
0.24
1.4
1.5
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
15
122
1.21
0.23
5.3
3.3
mmol/l
1.8
2.5
0.92
15
116
(3003327) Ova and parasites identified in Stool by Light microscopy
33
362
0.89
0.23
1.8
1.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
39
1.26
0.22
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
39
1.26
0.22
1.2
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
123
1.20
0.22
1.1
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
41
1.20
0.21
1.2
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
10
0.00
0.21
0.0
1.4
—
5.9
—
0
5
(3014271) Vancomycin [Susceptibility]
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
10
0.00
0.21
0.0
16.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
11
0.00
0.21
0.0
19.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
19.8
—
24.3
—
0
11
(3019225) pH of Specimen
30
329
0.89
0.21
3.9
5.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
5.6
—
3.6
—
0
12
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
42
1.17
0.21
7.0
8.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
18
205
0.86
0.21
1.4
4.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
47
1.26
0.20
1.0
1.2
iu/ml
226.2
201.9
—
6
47
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
14
0.00
0.20
0.0
1.4
—
316.4
—
0
8
(3035637) Corticotropin [Mass/volume] in Plasma
27
236
1.13
0.20
2.0
1.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
51
1.16
0.19
3.0
7.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
51
1.16
0.19
4.3
7.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
51
1.16
0.19
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
116
1.19
0.19
1.1
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
52
1.13
0.18
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
253
0.89
0.17
1.1
1.3
miu/ml
335.6
247.5
—
9
130
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
139
0.85
0.17
1.5
1.8
pmol/l
140.6
217.9
1.71
12
131
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
65
0.75
0.17
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
68
0.72
0.17
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
67
1.17
0.16
1.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
91
937
0.95
0.16
2.1
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
58
606
0.94
0.16
1.4
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
71
1.11
0.16
1.1
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
578
5621
1.04
0.15
3.7
3.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
58
604
0.94
0.15
3.0
2.6
ug/l
1.2
0.7
0.79
35
354
(3000330) Specific gravity of Urine by Test strip
26
232
1.10
0.14
3.0
2.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
84
0.82
0.14
1.7
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
85
0.81
0.14
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
85
0.81
0.14
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
45
471
0.93
0.14
1.3
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
166
0.89
0.12
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
42
438
0.94
0.12
3.8
3.6
%
32.4
31.9
0.11
33
310
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
598
0.95
0.12
3.4
2.4
u/l
29.7
31.5
0.20
53
492
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
350
1.07
0.11
2.5
2.0
u/ml
229.5
175.7
0.47
23
166
(40768804) Tissue Pathology biopsy report
178
1788
0.97
0.11
1.9
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
224
0.92
0.10
1.3
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
44
1.12
0.10
31.8
19.5
nmol/l
1571.0
1484.6
—
5
44
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
46
1.07
0.09
1.0
1.3
nmol/l
2.0
1.2
—
5
40
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
47
1.04
0.09
3.4
1.9
u/ml
607.4
1188.3
—
5
47
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
171
1.09
0.09
1.6
1.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
22
200
1.08
0.09
1.5
1.7
nmol/l
36.2
39.1
0.24
22
195
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
38
354
1.06
0.09
2.4
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
173
1667
1.02
0.08
4.0
4.2
mmol/l
7.0
8.1
2.22
158
1480
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
60
0.82
0.08
1.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
61
0.80
0.08
7.4
10.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
63
0.78
0.08
1.2
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
322
0.94
0.08
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
110
1054
1.03
0.08
3.6
3.5
mg/l
750.4
278.1
0.32
76
737
(3021788) Differential panel - Synovial fluid
7
67
1.03
0.07
1.7
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
76
1.03
0.07
1.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
82
0.84
0.07
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
20
183
1.08
0.07
1.5
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
91
0.86
0.06
1.1
1.3
%
77.4
76.6
—
8
91
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
91
0.86
0.06
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
252
1.05
0.06
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
58
586
0.97
0.05
2.0
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
108
0.91
0.05
2.3
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
138
0.92
0.05
1.5
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
26
267
0.95
0.04
1.7
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
117
0.92
0.04
2.4
2.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
129
1.07
0.03
1.3
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
236
1.04
0.03
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
67
646
1.02
0.03
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
116
0.93
0.03
1.3
1.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
106
0.93
0.03
1.2
1.3
pmol/l
104.5
69.7
—
10
101
(3002523) Influenza virus A Ag [Presence] in Specimen
25
237
1.04
0.02
1.2
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
159
1.05
0.02
2.9
1.9
iu/l
2.6
4.8
—
8
54
(3020682) Albumin/Creatinine [Ratio] in Urine
112
1089
1.01
0.02
4.4
4.2
mg/mmol
13.2
12.0
0.07
77
745
(3050129) First trimester maternal screen panel - Serum or Plasma
31
312
0.97
0.01
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
56
556
0.99
0.00
1.5
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
515
1.01
0.00
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
96
1.02
0.00
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
17
169
0.99
0.00
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
19
189
0.99
0.00
2.1
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
107
1053
1.00
0.00
4.0
3.9
ug/l
1.9
2.1
0.26
96
957
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
148
1.00
0.00
1.1
1.2
—
—
—
0
0
(4035726)
44
437
0.99
0.00
2.8
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
21
210
0.98
0.00
1.7
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
104
1.04
0.00
1.4
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
72
0.95
0.00
1.9
1.9
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
7
72
0.95
0.00
7.3
2.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
54
0.91
0.00
1.2
1.3
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
50
0.98
0.00
1.6
7.6
—
48.4
—
0
8
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
132.7
—
0
6
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.3
—
6845.3
—
0
8
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
74
0.93
0.00
1.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
68
0.87
0.00
1.2
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
69
1.00
0.00
1.0
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
4.6
—
0
6
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
227.3
—
0
6
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
2.7
—
0
8
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022670) pH of Venous cord blood
5
58
0.85
0.00
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
68
1.01
0.00
1.4
2.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
92
0.96
0.00
1.4
1.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.8
—
0.4
—
0
8
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
68
1.01
0.00
2.6
2.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_GREAT_ARTERIES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_GREAT_ARTERIES | 3.101 [2.4, 4.0] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.421 |
During the follow-up period (1.1.1998 — 31.12.2019), 246 out of 5292 females with Q17_CONGEN_MALFO_GREAT_ARTERIES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_GREAT_ARTERIES | 2.705 [2.21, 3.31] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 278 out of 5278 males with Q17_CONGEN_MALFO_GREAT_ARTERIES died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_GREAT_ARTERIES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.375% | 0.496% |
| 5 | 1.882% | 2.813% |
| 10 | 4.585% | 7.174% |
| 15 | 8.942% | 13.541% |
| 20 | 15.7% | 22.229% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_GREAT_ARTERIES – Congenital malformations of great arteries
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data